Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4 , Pages 364-367 , July 2008

Effect of perioperative blood transfusion on prostate cancer recurrence

  • Beneranda S. Ford, M.D.

      Affiliations

    • Department of Urology, University of Buffalo School of Medicine and Biotechnology, Buffalo, NY 14203, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-716-845-8433; fax: +1-716-845-3300.
    • ,
  • Satish Sharma, M.D.

      Affiliations

    • Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • Robotic Surgery Program, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • ,
  • Hamed Rezaishiraz, M.D.

      Affiliations

    • Department of Cancer Prevention, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • ,
  • Robert S. Huben, M.D.

      Affiliations

    • Department of Urology, University of Buffalo School of Medicine and Biotechnology, Buffalo, NY 14203, USA
    • Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • ,
  • James L. Mohler, M.D.

      Affiliations

    • Department of Urology, University of Buffalo School of Medicine and Biotechnology, Buffalo, NY 14203, USA
    • Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • Robotic Surgery Program, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

Received 23 March 2007 ,Revised 20 June 2007 ,Accepted 21 June 2007.

References 

  1. Swisher SG, Holmes EC, Hunt KK, et al. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg. 1996;112:341–348
  2. Fujimoto J, Okamoto E, Yamanaka N, et al. Adverse effect of perioperative blood transfusions on survival after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology. 1997;44:1390–1396
  3. Voogt PJ, van de Velde CJ, Brand A, et al. Perioperative blood transfusion and cancer prognosis (Different effects of blood transfusion on prognosis of colon and breast cancer patients). Cancer. 1987;15:836–84359
  4. Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusion on subsequent kidney transplants. Transplant Proc. 1973;5:253–259
  5. Amato AC, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer. Dis Colon Rectum. 1998;41:571–585
  6. Eickhoff JH, Gote H, Baeck J. Peri-operative blood transfusion in relation to tumor recurrence and death after surgery for prostate cancer. Br J Urol. 1991;68:608–611
  7. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg. 1988;156:374–380
  8. McClinton S, Moffat LE, Scott S, et al. Blood transfusion and survival following surgery for prostate carcinoma. Br J Surg. 1990;77:140–142
  9. Motoyama S, Saito R, Kamata S, et al. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer. Surg Today. 2002;32:951–958
  10. Sarle R, Bhandari A, Shah N, et al. The Vattikuti Institute prostatectomy: A single surgeon experience of 1,452 cases. Surg Laparosc Endosc Percutan Tech. 2006;16:293
  11. Alsikafi NF, Brendler CB. Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J Urol. 1998;159:1281–1285
  12. Amling CL, Bergstralh EJ, Blute ML, et al. Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?. J Urol. 2001;165:1146–1151
  13. Noh C, Kshirsagar A, Mohler JL. Outcomes after radical retropubic prostatectomy. Urology. 2003;61:412–416
  14. Nosotti M, Rebulla P, Riccardi D, et al. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage one lung cancer. Chest. 2003;124:102–107
  15. Han M, Partin AW, Zahurak M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for localized prostate cancer. J Urol. 2003;169:517–523
  16. Hyung WJ, Noh SH, Shin DW, et al. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Annals of Surgical Oncology. 2002;9:5–12
  17. Oefelein MG, Colangelo LA, Redemaker AW, et al. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol. 1995;154:442–447
  18. Paul R, Schmid R, Busch R, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology. 2006;67:137–141
  19. Johnson DE, Lanieri JP, Ayala AG. Prostatic adenocarcinoma occurring in men under 50 years of age. J Surg Oncol. 1972;4:207
  20. Khan FA, Kaisary AV, Boustead GB, et al. PSA recurrence following radical prostatectomy is comparable for all age groups in the UK. Prostate Cancer Prostat Dis. 2005;8:158–162
  21. Smith CV, Bauer JJ, Connelly RR, et al. Prostate cancer in men age 50 or younger: A review of the department of defense center for prostate disease research multicenter prostate cancer database. J Urol. 2000;164:1964–1967

PII: S1078-1439(07)00187-1

doi: 10.1016/j.urolonc.2007.06.004

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4 , Pages 364-367 , July 2008

Article Tools

* Image Usage & Resolution